Ingredient makers tell Nutrition Insight that companion products need trial evidence and careful claims, with HTBA pointing to fatigue on treatment.
Recap by typeshit. Full story at Nutrition Insight.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
18:51
A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
The FDA had warned the Cary, North Carolina pharmacy in December 2025 about sterile production problems. Check your vial's lot number and beyond-use date.
Kumar says month one is less about big drops on the scale and more about setting up habits that help the medication work over time.
Loading…